Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.

MLA

Hu, Si-Long, et al. “Role of SUV(Max) Obtained by 18F-FDG PET/CT in Patients with a Solitary Pancreatic Lesion: Predicting Malignant Potential and Proliferation.” Nuclear Medicine Communications, vol. 34, no. 6, June 2013, pp. 533–39. EBSCOhost, https://doi.org/10.1097/MNM.0b013e328360668a.

APA

Hu, S.-L., Yang, Z.-Y., Zhou, Z.-R., Yu, X.-J., Ping, B., & Zhang, Y.-J. (2013). Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation. Nuclear Medicine Communications, 34(6), 533–539. https://doi.org/10.1097/MNM.0b013e328360668a

Chicago

Hu, Si-Long, Zhong-Yi Yang, Zheng-Rong Zhou, Xian-Jun Yu, Bo Ping, and Ying-Jian Zhang. 2013. “Role of SUV(Max) Obtained by 18F-FDG PET/CT in Patients with a Solitary Pancreatic Lesion: Predicting Malignant Potential and Proliferation.” Nuclear Medicine Communications 34 (6): 533–39. doi:10.1097/MNM.0b013e328360668a.